Immunovant
Nicoliné P. is an experienced executive assistant and business manager with a diverse background in administrative support across various industries. Currently serving as EA to the CTO and SVP Global Head Quality Assurance at Immunovant since February 2024, Nicoliné transitioned from a contractor to a full-time role. Previous roles include interim EA to the CEO and CFO at Immunovant, co-founder and owner of merakimoyo, and EA and PA to the CBO of ElevateBio and COO of LifeEDIT Therapeutics. Nicoliné has demonstrated expertise in managing teams, strategic planning, and providing high-level support to executives in dynamic environments, with a proven track record in international communication and stakeholder engagement. Educational qualifications include a degree in Business Administration from Business School Stuttgart, Germany.
This person is not in any teams
This person is not in any offices
Immunovant
6 followers
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies.